Sessions and Speakers

2025 Global Myositis Patient Conference

September 18–21, 2025
Sheraton Dallas Hotel
Dallas, TX

Engaging and exciting content will unfold over three-plus days while we celebrate our worldwide myositis community. Stay tuned for details to come!

Conference Program Format

• General sessions: All conference attendees gather to be inspired by keynote speakers
• Breakout sessions: Conference attendees gather in smaller groups, based on interest or diagnosis, to learn about the latest science and living well with myositis
• Virtual breakout sessions: Held prior to the conference on Zoom
• Orientation and special event for first-time attendees
• Exhibit floor
• Networking opportunities

Our Distinguished Speakers

More than 50 speakers will enlighten and entertain TMA attendees this year, with experts and fellow myositis patients addressing the hottest topics. Presenters include:

• Helene Alexandersen, PhD, RPT, Associate Professor (Docent), Karolinska Institutet, Department of Medicine; TMA Medical Advisory Board
• Salman Bhai, MD, Assistant Professor, Department of Neurology, UT Southwestern Medical Center; Director, Neuromuscular Center, Institute of Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas
• Suur Biliciler, MD, Professor, Department of Neurology and Co-Director, Neurology Residency Program, McGovern Medical School, University of Texas Health Science Center at Houston
• Laurie Boyer, MBA, Cofounder and Former Vice President, Team Tommy Foundation; Chair, TMA Board of Directors
• Paula J. Eichenbrenner, MBA, CAE, Executive Director, TMA
• David Fiorentino, MD, PhD, Professor of Dermatology, Stanford Medicine; TMA Medical Advisory Board
• Richard (Chip) Galloway, Jr., Staff Accountant, Cantey, Tiller, Pierce & Green, LLP; TMA Board of Directors
• Namita A. Goyal, MD, Professor of Neurology, University of California, Irvine School of Medicine; Co-director, UC Irvine-MDA ALS and Neuromuscular Center; Director, Neuromuscular Medicine Fellowship; Chair, TMA Medical Advisory Board
• Janine Lamb, DPhil, Reader in Complex Human Genetics/Genomics, Programme Director for MRes in Translational Medicine, Faculty of Biology, Medicine and Health, University of Manchester; TMA Medical Advisory Board
• Thomas Lloyd, MD, PhD, Chair of Neurology, Baylor College of Medicine
• Tahseen Mozaffar, MD, Professor of Neurology, Pathology, and Laboratory Medicine and Orthopaedic Surgery, University of California, Irvine; TMA Medical Advisory Board and Liaison to TMA’s Board of Directors
• Julie Paik, MD, MHS, Associate Professor of Medicine, Johns Hopkins University; Co-director of the Johns Hopkins Myositis Center; Director of Clinical Trials, Johns Hopkins Myositis Center; Chair, TMA Medical Advisory Board
• Julie Sanfilippo, RDN, Diabetes Prevention Program Healthcoach, Elmhurst Memorial Healthcare
• Eleni Tiniakou, MD, Associate Professor of Medicine, University of Texas Health Science Center at Houston

Conference Content by Form of Myositis

Some sessions are organized by diagnosis and delivered to support you specifically. Wherever you are in your myositis journey, TMA has a medical advisor who can answer your most pressing questions.

• Back to Basics
• Ask the Experts
• Physical and Occupational Therapy
• Latest Scientific Findings
• Living with Myositis